Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-08 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.16 | 0.0003 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |